Health Catalyst to Announce Third Quarter 2025 Operating Results and Host Conference Call on Monday, November 10, 2025

Health Catalyst, Inc. (Nasdaq: HCAT), a prominent provider of data and analytics technology and services tailored for healthcare organizations, is set to announce its third quarter operating results for 2025 on November 10, 2025, following the market's close. In conjunction with this announcement, the company will hold a conference call at 5:00 PM ET the same day, allowing investors and analysts to engage directly with the management team to discuss the results in detail.

Participants in the conference call can join by dialing 800-343-5172 for U.S. callers or 203-518-9856 for those calling internationally, using the conference ID "HCATQ325" for reference. For those who prefer digital access, a live audio webcast will be available on Health Catalyst's investor relations website, with a replay accessible for about 90 days after the event.

Health Catalyst has established itself as a leader in driving intelligent healthcare improvement through its robust data analytics platforms and expert service offerings. The company’s technology ecosystem, Health Catalyst Ignite™, leverages AI-enabled solutions and comprehensive healthcare data, enabling over 1,100 organizations globally to convert complex healthcare information into actionable insights capable of achieving significant clinical, financial, and operational advancements. With a commitment to fostering meaningful improvements across millions of patient records, Health Catalyst continues to prove its ability to deliver substantial, measurable results in the healthcare sector.

For any investor inquiries, Matt Hopper, the Senior Vice President of Finance and Head of Investor Relations, is available at 855-309-6800 or via email at ir@healthcatalyst.com. Media inquiries can be directed to Kathryn Mykleseth at media@healthcatalyst.com.

As Health Catalyst, Inc. (Nasdaq: HCAT) prepares to announce its third-quarter operating results on November 10, 2025, investors should approach this event with a keen eye on several pivotal factors that could impact its stock performance. Given Health Catalyst’s position as a leading provider of data and analytics technology for healthcare organizations, the upcoming results will be indicative of its market resilience, particularly in a rapidly evolving healthcare landscape.

Firstly, investors should analyze the company’s revenue growth and profitability metrics. A consistent trend of revenue growth, especially in the context of recurring revenue from its cloud-based offerings, would signal strength in its business model. Additionally, any positive commentary regarding customer acquisitions or expansions could further enhance the company’s outlook, justifying a bullish investment stance.

Secondly, scrutiny should be given to Health Catalyst’s operational efficiencies and cost management strategies. The healthcare technology sector has been under pressure to demonstrate efficiency in both operations and capital deployment. If Health Catalyst shows improvement in its operating margins, this could bolster investor confidence.

Furthermore, consider the potential for innovation within its product offerings. The healthcare industry is increasingly leaning on AI and data analytics, and any advancements in its Ignite™ platform could provide Health Catalyst with a considerable competitive advantage. Investors should watch for details on new features, partnerships, or client case studies that support the effectiveness of its solutions.

Lastly, pay attention to macroeconomic factors and trends impacting the healthcare sector post-announcement. With rising healthcare costs and a growing emphasis on data-driven decision-making, Health Catalyst is well-positioned to benefit from these trends.

In conclusion, while upcoming earnings will provide critical insights into Health Catalyst’s health, investors should maintain a balanced perspective—considering both the immediate results and the broader industry landscape—in making informed investment decisions.